Contracepción sólo con gestágenos - Sociedad Española de ...

SOCIEDAD ESPAÑOLA DE CONTRACEPCIÓN
Sivin I, Campodonico I, Kiriwat O, Holma P, Diaz S, Wan L, et al. The performance of levonorgestrel rod and Norplant contraceptive
implants: a 5-year randomized study. Hum Reprod 1998;13:3371-3378.
Sivin I, Mishell DR, Diaz S et al. Prolonged effectiveness of Norplant ® capsules: a 7 year study. Contraception. 2000:61:3;187-94.
Skegg DCG, Noonan EA, Paul C, Spears GFS, Meirik O, Thomas DB. Depot medroxyprogesterone acetate and breast cancer: a pooled
análisis of the World Health Organization and the New Zealand studies. JAMA 1995; 273:799.
Speroff l, Glass RH, Kase NG. Oral contraception. In: Clinical Ginecologic endocrinologic and fertility. 6th. Baltimore: Lippincott
Williams & Wilkins, 1999:867-945 (Nivel III).
Speroff L, Glass RH, Kase NG. Oral contraception. In: Clinical gynecologic endocrinology and infertility. 6th. Baltimore: Lippincott
Williams & Wilkins, 1999:867-945. (Nivel III).
Stillwell S, Sheppard P, Searle S. The impalpable Implanon: a case report. J Fam Plann Reprod health Care2003.;29(3):156-157.
Summary of Product Characteristics for Implanon. Organon. 1-4. 2002.
Truitt ST, Fraser AB, Grimes DA, Gallo MF, Schulz KF. Hormonal contraception during lactation. systematic review of randomized
controlled trials. Contraception 2003 Oct; 68(4): 233-8.
Vasilakis C, Jick H, del Mar Melero-Montes M. Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet
1999;354:1610-1.
Westerway SC, Picker R, Christie J. Implanon detection with ultrasound and magnetic resonance imaging. Aust N Z Obstet Gynaecol.
2003;43(5):346-50
WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and depot-medroxyprogesterone acetate: a
multinational study. Lancet 1991a; 338:833. (Nivel II-2).
WHO Task Force for Epidemiological Research on Reproductive Health. Progestogen-only contraceptives during lactation: II. Infant
development. Contraception 1994; 50:55-68. (Nivel II-2).
WHO Task Force on Oral Contraceptives. Effects of hormonal contraceptives on breast milk composition and infant growth. Stud
Fam Plann 1988; 19:361-369. (Nivel II-2).
Winkler, UH, Howie, H, Buhler,K et al. A randomised controlled double-blind study of the effects on haemostasis of two progestogenonly
pills containing 75 microgram desogestrel or 30 microgram levonorgestrel. Contraception 1998; 57: 385-392
World Health Organization, Family and Reproductive Health Programme. Improving Access to Quality Care in Family Planning. Medical
Eligibility Criteria for Contraceptive Use, 2nd ed. Geneva, World Health Organization, 2000. (Nivel III).
World Health Organization. Cardiovascular disease and use of oral and injectable progestagen only contraceptives and combine
injectable contraceptives. Results of an international, multicentre, case control study. Contraception 1998;57:315-24.
World Health Organization. Cardiovascular disease and use of Steroid Hormonal Contraception, Venous thromboembolic disease
and combined oral contraceptives: results of a multicentre case-control study. Lancet 1996;345:1575-82.
World Health Organization. Improving Access to Quality Care in Family Planning - Medical Eligibility Criteria for Contraceptive Use.
Third edition. 2004. World Health Organization.
World Health Organization. Selected practice recommendations for contraceptive use. 2002. World Health Organization ISBN 92
154566 6. Ref Type: Report
Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF. A Randomized Multicenter Study Comparing the Efficacy and Bleeding Pattern of
a Single-Rod (Implanon) and a Six-Capsule (Norplant) Hormonal contraceptive Implant. Contraception 1999; 60:1-8.
273